In our study, we found a significantly higher occurrence of the G:C > T:A transition in the TP53 mutation pattern in gastric cancer patients from Rwanda compared to those from non-African countries such as China, Hungary, Japan, Poland, Romania, the USA, and Hong Kong [33, 43, 52]. The gene discussed is TP53; the disease is gastric cancer.